After Cellular Origins announced its latest collaboration with Johnson & Johnson, Olivia Friett spoke to Edwin Stone, CEO, Cellular Origins about the collab and the future of mobile robotics.
OutSee has announced it has secured £1.8M in seed funding, led by Ahren Innovation Capital and with additional investment from Kadmos Capital, Empirical Ventures and Panacea Ventures.
INTEGRA Biosciences’ liquid handling solutions and pipette automation software are helping 3T Biosciences to enhance the reproducibility and productivity of its pipetting workflows, accelerating the discovery of novel cancer targets and therapeutics.
Antares Vision Group in collaboration with Oròbix has introduced AI-GO, an artificial intelligence-driven visual inspection platform that elevates standards across several key performance indicators.
Cellular Origins, a TTP Company, focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), has announced an international collaboration with Thermo Fisher Scientific.
Roger Gaemperle, industry strategy & marketing manager – consumer packaged goods & life science EMEA at Rockwell Automation discusses the role of MES in biopharma.
Updesh Dosanjh, practice leader, Pharmacovigilance Technology Solutions, IQVIA explains how Artificial intelligence (AI) is now deeply embedded in pharmaceutical operations, especially in pharmacovigilance.
Median Technologies will be participating in the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting taking place from 30th May - 2nd June, McCormick Place, Chicago, IL, USA.
Process industry software specialist, eschbach, has won the German Innovation Award for its use of artificial intelligence (AI) to drive productivity and efficiency in the chemical and pharmaceutical industries.
Domino Data Lab, provider of the Enterprise AI platform, has announced continued life sciences traction and new capabilities to bridge a critical industry gap.
